$RANI Income Statement | Understand Stock

$RANI

$0.61 -$0.01 (1.28%) Close

$RANI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Contract revenue
Operating expenses
Research and development
General and administrative
Impairment loss
Total operating expenses
Loss from operations
Other income (expense), net
Interest income
Interest income and other, net
Interest expense and other, net
Change in estimated fair value of preferred unit warrant

Loss before income taxes
Income tax expense (benefit)
Loss on extinguishment of debt
Net loss
Net loss attributable to non-controlling interest
Net loss attributable to Rani Therapeutics Holdings, Inc.
Common Class A
Total net loss attributable to Rani Therapeutics Holdings, Inc.
Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc., basic and diluted
Weighted-average Class A common shares outstanding-basic and diluted
Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc.-basic
Common Class A
Total net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc.-basic
Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc.-diluted
Common Class A
Total net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc.-diluted
Weighted average Class A common share outstanding-basic
Common Class A
Total weighted average Class A common share outstanding-basic
Weighted average Class A common share outstanding-diluted
Common Class A
Total weighted average Class A common share outstanding-diluted

Comments